Ribavarin should be tested in clinical trials in combination with other antiviral agents for severe acute respiratory syndrome.
Chu
Chung-Ming
CM
Chan
Kin-Sang
KS
D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002423:Cause of Death; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006801:Humans; D020380:Needs Assessment; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use; D018570:Risk Assessment; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality*; D015996:Survival Rate
D000998:Antiviral Agents; D012254:Ribavirin